Wide field of view 3D microscopy for calcium imaging and photostimulation

Information

  • Research Project
  • 9201872
  • ApplicationId
    9201872
  • Core Project Number
    R43MH111463
  • Full Project Number
    1R43MH111463-01
  • Serial Number
    111463
  • FOA Number
    PA-15-269
  • Sub Project Id
  • Project Start Date
    8/10/2016 - 7 years ago
  • Project End Date
    7/31/2017 - 6 years ago
  • Program Officer Name
    GRABB, MARGARET C.
  • Budget Start Date
    8/10/2016 - 7 years ago
  • Budget End Date
    7/31/2017 - 6 years ago
  • Fiscal Year
    2016
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/10/2016 - 7 years ago
Organizations

Wide field of view 3D microscopy for calcium imaging and photostimulation

Project Summary/Abstract Mental disease, including schizophrenia, depression and autism spectrum disorders, are still poorly understood, although it is clear that they mostly represent cortical disorders. The cortex is the primary site of higher mental functions, and despite extensive research, there is still no unified theory of how the cortex works. This is partly due to the fact that neuroscientists have traditionally relied on microelectrodes to record the activity of individual cells. However, cortical circuits are composed of millions of neurons and it is conceivable that single cell measurements alone will not be sufficient to unravel function of the brain. Optical imaging techniques tackle this emergent level of neuronal circuit activity and enable to image the activity of neuronal ensembles, in vitro and in vivo, while preserving single cell resolution, something that brain imaging techniques such as MRI or PET, cannot do. Moreover, the development of genetically encoded photosensitive proteins (optogenetics) and optochemical (caged) compounds offers the opportunity to not only image the activity of many neurons but also to optically control them. Advances in optogenetics has led to the development of two-photon microscopes combined with spatial light modulators (SLM), that allow the customer to split the laser beam into a holographic pattern that can be used to image activity or photoactivate neurons simultaneously in 3D. Multiple commercially available microscopes are now offered. Additionally researchers are customizing their own microscopes as a low cost alternative to purchasing new commercially available microscopes. The Meadowlark Optics (MLO) SLM is preferentially utilized due to the unprecedented response time a factor of 8 faster than competing SLMs, enabling more complex studies of brain function. However, the limited resolution of the SLM leads to studies over a smaller volume, and low fill factor leads to optical losses. To address these concerns MLO is proposing the development of a high speed (142 Hz to 500 Hz), high fill factor (95%), high resolution SLM. To reduce cost, and time to market MLO proposes to utilize an existing backplane, representing a total savings of $1M, and 1 year of development. Meadowlark will realize a prototype system within the Phase I, and will utilize internal funds to complete the product.

IC Name
NATIONAL INSTITUTE OF MENTAL HEALTH
  • Activity
    R43
  • Administering IC
    MH
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    469426
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    242
  • Ed Inst. Type
  • Funding ICs
    NIMH:469426\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MEADOWLARK OPTICS, INC.
  • Organization Department
  • Organization DUNS
    109079004
  • Organization City
    FREDERICK
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    805046412
  • Organization District
    UNITED STATES